Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial

NCT02262923 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mount Sinai Hospital, Canada